AbCellera Biologics Inc. (ABCL)Healthcare | Biotechnology | Vancouver, Canada | NasdaqGS
3.91 USD
+3.91
(-2.494%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 1:05 a.m. EDT
AbCellera is a speculative biotech dime store played on the hope for a 10x base gene therapy underlying, but the data paints a deterioration picture: negative earnings, negative free cash flow, negative gross margins, and a firmament founded on high PE and debt. With a short ratio of 18x and no dividends, the risk is extreme. The long-term outlook is a buy trap, but the short-term momentum is supported by aggressive call speculation despite the negative statistical forecast. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.150758 |
| AutoTheta | 0.153385 |
| AutoETS | 0.153432 |
| MSTL | 0.166342 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.407 |
| Excess Kurtosis | 0.13 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 14.812 |
| Revenue per Share | 0.252 |
| Market Cap | 1,185,357,440 |
| Forward P/E | -4.99 |
| Beta | 0.85 |
| Profit Margins | -194.88% |
| Website | https://www.abcellera.com |
As of April 19, 2026, 1:05 a.m. EDT: Options flow is dominated by deep Out-of-The-Money (OTM) long calls (6.0 and 7.0 strikes) with high implied volatility, suggesting aggressive speculative speculation on a significant upside move to targets around $7+. However, significant Put OI clings to OTM strikes (3.0 and 2.0 in longer tenors), indicating a hedge against downside. Notably, the 10-exp has seen new flow into 4.0 strikes for puts, suggesting some near-term defensive positioning as the stock approaches $4. The 45-day adjusted forecast predicts -3.46% downside, conflicting slightly with the call-heavy flow but weighted heavily towards continuation of recent volatility.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.55158734 |
| Address1 | 150 W 4th Avenue |
| All Time High | 71.91 |
| All Time Low | 1.891 |
| Ask | 3.94 |
| Ask Size | 14 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 3,292,920 |
| Average Daily Volume3 Month | 3,564,370 |
| Average Volume | 3,564,370 |
| Average Volume10Days | 3,292,920 |
| Beta | 0.846 |
| Bid | 3.89 |
| Bid Size | 16 |
| Board Risk | 9 |
| Book Value | 3.217 |
| City | Vancouver |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 7 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.91 |
| Current Ratio | 11.324 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 4.03 |
| Day Low | 3.88 |
| Debt To Equity | 14.812 |
| Display Name | AbCellera Biologics |
| Earnings Call Timestamp End | 1,778,533,200 |
| Earnings Call Timestamp Start | 1,778,533,200 |
| Earnings Timestamp | 1,778,529,600 |
| Earnings Timestamp End | 1,778,529,600 |
| Earnings Timestamp Start | 1,778,529,600 |
| Ebitda | -194,932,000 |
| Ebitda Margins | -2.59467 |
| Enterprise To Ebitda | -4.077 |
| Enterprise To Revenue | 10.579 |
| Enterprise Value | 794,749,504 |
| Eps Current Year | -0.7075 |
| Eps Forward | -0.78333 |
| Eps Trailing Twelve Months | -0.49 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.4398 |
| Fifty Day Average Change | 0.47020006 |
| Fifty Day Average Change Percent | 0.13669401 |
| Fifty Two Week Change Percent | 55.158733 |
| Fifty Two Week High | 6.515 |
| Fifty Two Week High Change | -2.6049998 |
| Fifty Two Week High Change Percent | -0.3998465 |
| Fifty Two Week Low | 1.94 |
| Fifty Two Week Low Change | 1.97 |
| Fifty Two Week Low Change Percent | 1.015464 |
| Fifty Two Week Range | 1.94 - 6.515 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,607,697,000,000 |
| Float Shares | 206,791,831 |
| Forward Eps | -0.78333 |
| Forward P E | -4.9915104 |
| Free Cashflow | -175,997,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 562 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | -1.48681 |
| Gross Profits | -111,701,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.22752 |
| Held Percent Institutions | 0.37341 |
| Implied Shares Outstanding | 303,160,487 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,020-12-11 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada. |
| Long Name | AbCellera Biologics Inc. |
| Market | us_market |
| Market Cap | 1,185,357,440 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_280568380 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -146,412,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,185,357,504 |
| Number Of Analyst Opinions | 7 |
| Open | 4.015 |
| Operating Cashflow | -131,295,000 |
| Operating Margins | -0.63724 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 604 559 9005 |
| Pre Market Change | 0.1547997 |
| Pre Market Change Percent | 3.9590716 |
| Pre Market Price | 4.0648 |
| Pre Market Time | 1,776,759,395 |
| Previous Close | 0.0 |
| Price Eps Current Year | -5.526502 |
| Price Hint | 4 |
| Price To Book | 1.2154181 |
| Price To Sales Trailing12 Months | 15.777839 |
| Profit Margins | -1.94883 |
| Quick Ratio | 10.074 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | 3.91 |
| Regular Market Change Percent | -2.49377 |
| Regular Market Day High | 4.03 |
| Regular Market Day Low | 3.88 |
| Regular Market Day Range | 3.88 - 4.03 |
| Regular Market Open | 4.015 |
| Regular Market Previous Close | 0.0 |
| Regular Market Price | 3.91 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 5,197,809 |
| Return On Assets | -0.09986 |
| Return On Equity | -0.14475 |
| Revenue Growth | 7.882 |
| Revenue Per Share | 0.252 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 303,160,487 |
| Shares Percent Shares Out | 0.1663 |
| Shares Short | 50,425,478 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 51,320,387 |
| Short Name | AbCellera Biologics Inc. |
| Short Percent Of Float | 0.2149 |
| Short Ratio | 18.79 |
| Source Interval | 15 |
| State | BC |
| Symbol | ABCL |
| Target High Price | 12.0 |
| Target Low Price | 7.0 |
| Target Mean Price | 9.42857 |
| Target Median Price | 10.0 |
| Total Cash | 533,825,984 |
| Total Cash Per Share | 1.761 |
| Total Debt | 143,218,000 |
| Total Revenue | 75,128,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Eps | -0.49 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.1356 |
| Two Hundred Day Average Change | -0.2256 |
| Two Hundred Day Average Change Percent | -0.05455073 |
| Type Disp | Equity |
| Volume | 5,197,809 |
| Website | https://www.abcellera.com |
| Zip | V5Y 1G6 |